Vir Biotechnology Launches To Cure, Treat, And Prevent Challenging Infectious Diseases Using Latest
-Former Biogen leader George Scangos will be CEO, with Vicki Sato as Chairman of the Board -Company to apply immune programming at...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
- Dec 6, 2016
Sienna Biopharmaceuticals Acquires Creabilis plc
Acquisition Adds Phase IIb Product, Clinical Candidates and Novel Discovery Platform to Sienna's Growing Pipeline WESTLAKE VILLAGE,...
- Oct 20, 2016
BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BlackThorn Therapeutics, a clinical stage biopharmaceutical company discovering and...
- Jul 21, 2016
Indigo Raises $100M in Series C Funding; Company Launches First Commercial Product for Water Efficie
BOSTON, MASS. — July 21, 2016 — Indigo, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announced...
- Jul 12, 2016
Sienna Biopharmaceuticals Announces Second Closing of Series A Financing
STRONG INVESTOR DEMAND INCREASES TOTAL INVESTMENTS TO $46M Westlake Village, CA, July 12, 2016 – Sienna Biopharmaceuticals, Inc....
- Jan 5, 2016
Millendo Therapeutics snags $62 Million Series B
Ann Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan...
- Dec 23, 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
SAN DIEGO, December 22, 2015 – eFFECTOR Therapeutics, a biopharmaceutical company developing translation regulators for the treatment of...
bottom of page